BRCA2 and cancer: Since the first reports of pathogenic variants in BRCA1 and BRCA2, the breast- and ovarian cancer-predisposing genes (CPGs), almost 30 years ago [1,2], it is increasingly evident that there are unlikely to be other major high-risk genes contributing to these cancers.